EAU22 game-chaning session webcast “Discussant: Overall survival with darolutamide versus placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS Trial” by Dr. Radtke.
Watch the webcast of “Overall survival with darolutamide versus placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS Trial” by Prof. Tombal here.